Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
64
UTI Quote, Financials, Valuation and Earnings
Last price:
$25.30
Seasonality move
:
0.69%
Day range:
$24.95 - $25.84
52-week range:
$11.59 - $26.71
Dividend yield:
0%
P/E ratio:
34.18x
P/S ratio:
1.76x
P/B ratio:
5.25x
Volume:
574.5K
Avg. volume:
574.7K
1-year change:
124.4%
Market cap:
$1.4B
Revenue:
$732.7M
EPS (TTM):
$0.74
Analysts' Opinion
-
Consensus RatingUniversal Technical Institute has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $26.33, Universal Technical Institute has an estimated upside of 4.13% from its current price of $25.29.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $22.00 representing 13.01% downside risk from its current price of $25.29.
Fair Value
-
According to the consensus of 5 analysts, Universal Technical Institute has 4.13% upside to fair value with a price target of $26.33 per share.
UTI vs. S&P 500
-
Over the past 5 trading days, Universal Technical Institute has overperformed the S&P 500 by 0.13% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Universal Technical Institute does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Universal Technical Institute has grown year-over-year revenues for 14 quarters straight. In the most recent quarter Universal Technical Institute reported revenues of $196.4M.
Earnings Growth
-
Universal Technical Institute has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Universal Technical Institute reported earnings per share of $0.34.
Enterprise value:
1.3B
EV / Invested capital:
3.45x
Price / LTM sales:
1.76x
EV / EBIT:
20.25x
EV / Revenue:
1.82x
PEG ratio (5yr expected):
0.06x
EV / Free cash flow:
21.59x
Price / Operating cash flow:
20.88x
Enterprise value / EBITDA:
11.38x
Gross Profit (TTM):
$348.2M
Return On Assets:
5.79%
Net Income Margin (TTM):
5.73%
Return On Equity:
17.79%
Return On Invested Capital:
11%
Operating Margin:
13.25%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $418.8M | $607.4M | $732.7M | $170.3M | $196.4M | |
| Gross Profit | $211.5M | $277.5M | $348.2M | $77.1M | $97M | |
| Operating Income | $22.4M | $21.4M | $58.9M | $10.3M | $26M | |
| EBITDA | $55.2M | $73.6M | $116.9M | $23.6M | $40.8M | |
| Diluted EPS | $0.38 | $0.11 | $0.74 | $0.10 | $0.34 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $180.2M | $183.4M | $136M | $205M | $222M | |
| Total Assets | $442M | $512.6M | $552.9M | $740.7M | $744.6M | |
| Current Liabilities | $121.6M | $132.7M | $137.7M | $184.7M | $205M | |
| Total Liabilities | $265.5M | $324M | $337.5M | $514.7M | $484.3M | |
| Total Equity | $176.5M | $188.5M | $215.4M | $226M | $260.2M | |
| Total Debt | $260K | $30.7M | $67.5M | $162.1M | $125.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $46M | $49.1M | $85.9M | $53.9M | $67.5M | |
| Cash From Investing | -$134.6M | -$44.1M | -$24M | -$7.8M | -$7.5M | |
| Cash From Financing | $12.6M | $81.8M | -$51.3M | -$3.2M | -$11.7M | |
| Free Cash Flow | -$33.4M | -$7.5M | $61.6M | $46M | $60M | |
UTI
Sector
Market Cap
$1.4B
$483.3M
Price % of 52-Week High
94.68%
72.36%
Dividend Yield
0%
0%
Shareholder Yield
--
3.61%
1-Year Price Total Return
124.4%
-11.07%
Beta (5-Year)
1.483
0.973
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
2.61%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$25.77
200-day SMA
Buy
Level
$17.19
Bollinger Bands (100)
Buy
Level
15.21 - 22.53
Chaikin Money Flow
Buy
Level
14.7M
20-day SMA
Sell
Level
$25.68
Relative Strength Index (RSI14)
Buy
Level
58.72
ADX Line
Sell
Level
7.14
Williams %R
Neutral
Level
-36.4103
50-day SMA
Buy
Level
$21.02
MACD (12, 26)
Buy
Level
1.24
25-day Aroon Oscillator
Buy
Level
84
On Balance Volume
Sell
Level
-14.8M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.459)
Sell
CA Score
(Annual)
Level (-0.4715)
Buy
Beneish M-Score
(Annual)
Level (-2.5648)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (0.8224)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Universal Technical Institute Inc is an educational institution. It provides undergraduate degree, as well as certificate programs for technicians in the automotive, diesel, collision repair, motorcycle and marine fields. The company's reportable segment which includes Universal Technical Institute (UTI) and Concorde Career Colleges, Corporate. Majority of the revenue is generated from UTI segment which provides different kinds of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute, Marine Mechanics Institute and others. It also provides dealer technician training or instructor staffing services to manufacturers.
Stock Forecast FAQ
In the current month, UTI has received 5 Buy ratings 0 Hold ratings, and 0 Sell ratings. The UTI average analyst price target in the past 3 months is $26.33.
-
Where Will Universal Technical Institute Stock Be In 1 Year?
According to analysts, the consensus estimate is that Universal Technical Institute share price will rise to $26.33 per share over the next 12 months.
-
What Do Analysts Say About Universal Technical Institute?
Analysts are divided on their view about Universal Technical Institute share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Universal Technical Institute is a Sell and believe this share price will drop from its current level to $22.00.
-
What Is Universal Technical Institute's Price Target?
The price target for Universal Technical Institute over the next 1-year time period is forecast to be $26.33 according to 5 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is UTI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Universal Technical Institute is a Buy. 5 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of UTI?
You can purchase shares of Universal Technical Institute via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Universal Technical Institute shares.
-
What Is The Universal Technical Institute Share Price Today?
Universal Technical Institute was last trading at $25.30 per share. This represents the most recent stock quote for Universal Technical Institute. Yesterday, Universal Technical Institute closed at $25.29 per share.
-
How To Buy Universal Technical Institute Stock Online?
In order to purchase Universal Technical Institute stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
